Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 6,466
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
Joanna Hill
ID:
Understanding movement patterns and habitat use of crop raiding African elephants in Northern Murchison Falls Conservation Area, Uganda
REFNo: NS80ES

Objective 1: Create an elephant identification database Objective 2: Determine range patterns and habitat use of elephants using GPS collars Objective 3:Create human and elephant activity maps using satellite imagery Objective 4: Design a package of conflict and poaching reduction measures
 UK 2018-12-20 2021-12-20 Natural Sciences Non-degree Award
Adrienne Guignard
ID:
The semantics of the alarm calling system of wild blue monkeys
REFNo: NS67ES

Examine empirically if blue monkeys maximise informativity when producing vocalizations and interpret calls as a function of the meaning of other calls
 Switzerland 2018-12-19 2021-12-19 Natural Sciences Degree Award
Andrew Mujugira
ID: UNCST-2019-R000871
 HIV self-testing to increase testing of male partners in antenatal care in Uganda
REFNo: HS273ES

Primary objective: Determine whether secondary distribution of HIV self-testing to male partners of HIV-negative pregnant women increases the proportion of male partners who test for HIV compared to standard of care invitation letters for fast track testing. Secondary objective: Evaluate whether HIV testing of male partners is associated with PrEP interest among HIV-negative women whose partner tests HIV-positive or refuses testing.
Uganda 2018-12-11 2021-12-11 Medical and Health Sciences Non-degree Award
Christine  Wiltshire Sekaggya
ID: UNCST-2019-R000578
 A randomized, four-arm open label Phase IIb clinical trial to evaluate the Pharmacokinetics, Safety/tolerability and Efficacy of High Dose Rifampicin in TB-HIV co-infected patients on Efavirenz- or dolutegravir-based antiretroviral therapy (SAEFRIF)
REFNo: HS262ES

Primary objective 1. To determine the effect of a high dose of rifampicin (35 mg/kg orally) on the pharmacokinetics of first-line antiretroviral drugs (efavirenz and dolutegravir) in TB-HIV co-infected patients on TB treatment. Secondary objectives 1. To investigate the safety/tolerability of a high dose of rifampicin in TB-HIV co-infected patients on TB treatment and first-line antiretroviral therapies. 2. To determine if TB-HIV co-infected patients on a high dose of rifampicin are more likely to have negative sputum cultures by the end of the intensive phase of TB treatment than patients on standard-dose rifampicin. 3. To explore the relationships between exposure to rifampicin, efavirenz and dolutegravir and the tolerability and efficacy of these drugs (Pharmacokinetic-Pharmacodynamic analysis).
Uganda 2018-12-04 2021-12-04 Medical and Health Sciences Non-degree Award
Nurait Nambogo
ID:
Mobile based application for appointment scheduling by health professionals
REFNo: HS251ES

•To assess the acceptability of MobiCare among health professionals and Patients/Clients. •To pilot test MobiCare application at selected private health facilities in Mbarara municipality.
Uganda 2018-12-04 2021-12-04 Medical and Health Sciences Non-degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."

NRIMS